Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling.
about
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophExtracellular Vesicles Secreted by Hypoxic AC10 Cardiomyocytes Modulate Fibroblast Cell Motility
P2860
Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@en
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@nl
type
label
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@en
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@nl
prefLabel
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@en
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@nl
P2093
P2860
P50
P356
P1476
Cardiac myocyte β3-adrenergic ...... dependent paracrine signaling.
@en
P2093
Andreas Markl
Anne Van Steenbergen
Caroline Bouzin
Christophe Beauloye
Christophe De Meester
Henri Colin
Hrag Esfahani
Joanna Hammond
Lauriane Michel
Nerea Hermida
P2860
P356
10.1093/EURHEARTJ/EHX366
P577
2017-07-06T00:00:00Z